KLEIN MATTHEW B. (Chief Development Officer) sold 0.7% of their position (2.85K shares) of PTC THERAPEUTICS, INC. on the open market
Open‑market sale worth $202.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/23/2026ACC: 0001808968-26-000013
Officer· Chief Development Officer
Since Apr 2020
-2.85K
Net shares
Net seller
$202.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.85K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.85K
Price / share
$70.91
Trade value
$202.09K
% of position
0.7%
4/21/2026
396.92K→394.07K
Total
Net shares
−2.85K
Net value
-$202.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/21/2026 | S · Sale | −2.85K | $70.91 | $202.09K | 0.7% | 396.92K | 394.07K |
| Total | −2.85K | -$202.09K | ||||||
Derivative Transactions0
No derivative transactions reported